An Interview With Dr. Antón Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Antón Blatnik, PhD, who recently won a $150,000 grant from Cure SMA to study the molecular mechanisms that drive neuromuscular disease and gene expression.